Ignite Creation Date:
2024-05-06 @ 1:23 PM
Last Modification Date:
2024-10-26 @ 1:13 PM
Study NCT ID:
NCT04009499
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-24
First Post:
2019-07-02
Brief Title:
A Study to Assess the Long-term Safety Tolerability and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma